TS
BSX icon

Triglav Skladi’s Boston Scientific BSX Stock Holding History

Triglav Skladi’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Hold
29,500
– – 0.07% 130
2026
Q1 		$1.85M Buy
29,500
+7,500
+34% +$600K 0.13% 98
2025
Q4 		$2.1M Sell
22,000
-7,000
-24% -$686K 0.13% 93
2025
Q3 		$2.83M Hold
29,000
– – 0.19% 67
2025
Q2 		$3.11M Hold
29,000
– – 0.23% 66
2025
Q1 		$2.93M Hold
29,000
– – 0.24% 65
2024
Q4 		$2.59M Buy
+29,000
New +$2.55M 0.2% 62

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Triglav Skladi's BSX Position: Q2 2026 in Review

Triglav Skladi held its Boston Scientific (BSX) position steady in Q2 2026 at 29,500 shares worth $1.26M. The position accounts for 0.07% of the portfolio, ranked #130.

Triglav Skladi first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.11M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Triglav Skladi held 29,500 shares of Boston Scientific worth $1.26M as of Q2 2026.
  • Triglav Skladi left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.07% of Triglav Skladi's portfolio in Q2 2026, its #130 holding.
  • Triglav Skladi first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Triglav Skladi's Boston Scientific position peaked at $3.11M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.